mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses against the JN.1 sublineages of SARS-CoV-2 in mice

Related articles

1. mRNA-1273.251 and mRNA-1283.251 vaccines expressing SARS-CoV-2 variant LP.8.1 antigens broadly neutralize contemporary JN.1-lineage viruses

   This article has 29 authors:

   1. Arshan Nasir
   2. Diana Wing Lee
   3. Ziqiu Wang
   4. Clinton Ogega
   5. Nathen Bopp
   6. Phylicia Wisti
   7. Dan Makrinos
   8. Hardik Jani
   9. Amy Gorrie
   10. Michael F Bender
   11. Adrian R Laciak
   12. Arvind Sharma
   13. Xiaozhen Hu
   14. Tessa Speidel
   15. Fadi Ghantous
   16. Daniela Montes Berrueta
   17. Yixuan Jacob Hou
   18. Kath Hardcastle
   19. Sayda Elbashir
   20. Cathal Harmon
   21. Nicholas J Amato
   22. Kai Wu
   23. William R Scheif
   24. Kiera Hohn
   25. Andrea Carfi
   26. Yadunanda Budigi
   27. Rahnuma Wahid
   28. Darin K Edwards
   29. Alec W Freyn

2. Impact of LP.8.1-Adapted mRNA Vaccination on SARS-CoV-2 Variant Neutralisation

   This article has 10 authors:

   1. C Happle
   2. M Hoffmann
   3. MV Stankov
   4. I Nehlmeier
   5. A Eichmann
   6. T Witte
   7. L Manthey
   8. S Pöhlmann
   9. A Dopfer-Jablonka
   10. GMN Behrens

3. Co-administration of intranasal parainfluenza virus vaccines expressing antigenically distinct SARS-CoV-2 S antigens elicits broad and durable immunity in hamsters

   This article has 12 authors:

   1. Hong-Su Park
   2. Yumiko Matsuoka
   3. Celia Santos
   4. Eleanor F. Duncan
   5. Jaclyn A. Kaiser
   6. Lijuan Yang
   7. Cindy Luongo
   8. Xueqiao Liu
   9. I-Ting Teng
   10. Peter D. Kwong
   11. Ursula J. Buchholz
   12. Cyril Le Nouën